News and Comments

Elan's Choices

  Saturday, April 16, 2011

Biogen Idec (BIIB) announced positive results of a process aimed at Identifying high-risk patients for a life-threatening side effect of prolonged use of the multiple sclerosis drug Tysabri. This test is a necessity because it detects an antibody that points to the presence of the Polyomavirus JC (JC virus), which causes the life-threatening progressive multifocal leukoencephalopathy (PML). This side effect in one per thousand patients has deprived Elan from billions of dollars in expected sales of Tysabri.  More...


Recent Postings


Archive


Tags

Vertex (VRTX) Jazz Pharmaceuticals (JAZZ) Pluristem (PSTI) Theravance (THRX) GUARDIAN HEALTH Dynavax (DVAX) Revlimid (lenolidamide) Anadys (ANDS) Prolor Biotech (PBTH) Aimmune Therapeutics (AIMT) Onyx (ONXX) Theravance Bio Pharma (TBPH) Multiple Myeloma AERIE PHARMACEUTICALS Sequenom (SQNM) TOKAI (TKAOI) Abbott Laboratories (ABT) Telaprevir JUNO (JUNO) Tysabri Micromet (MITI) NEKTAR (NKTR)) ARCA (ABIO) Roche (ROCHE) AstraZeneca (AZN) Cytokinetics (CYTK) galapagos (GLPG) Endometrial Cancer Gilead (GILD) VANDA (VNDA) Illumina (ILMN) Sanofi (SNY) Bristol-Myers Squibb (BMY) Alnylam (ALNY) KERYX (KERX) IDERA (IDRA) KITE (KITE) Array Pharmaceuticals (ARRY) Ziofpharm (ZIOP) Rapamune Herceptin Human Longevity (HLI) Seattle Genetics (SGEN) NOVOCURE (NVCR) CompuGen (CGEN) Spike Therapeutics (ONCE) Sanofi (SNA) Vitae Pharmaceuticals (VTAE) Elan (ELN) Alder Biopharmaceuticals (ALDR) Genentech Intermune (ITMN) Exelixis (EXEL) Merck (MRK) Mirati Therapeutics (MRTX) SUNESIS PHARMACEUTICALS (SNSS) Zerenex Anacor (ANAC) Human Genome Sciences (HGSI) Biogen Idec (BIIB) Biocryst (BCRX) ACADIA (ACAD) OSI (OSIP) MODERNA C4 Therapeutics Sarepta (SRPT) Incyte (INCY) ARGOS (ARGS) ABBVIE (ABBV) Agenus (AGEN) ISIS (ISIS) RenenxBio (RGNX) REGULUS (RGLS) Roche (RHHBY) Amgen (AMGN) Idenix (IDIX) Xoma (XOMA) Sanofi-Aventis (SAN) ImmunoGen (IMGN) GlaxoSmithKline (GSK) PTC Therapeutics (PTCT) Intercept (ICPT) SERES THERAPEUTICS (MCRB) Agenus (AGEN Trastuzumab-DM1 Velcade (bortezomib) NANTKWEST (NK) AGOS (ARGS) Global Cell Therapeutics (GBT) ADVENTRIX (ANX) SYNTA (SNTA) Valeant Pharmaceuticals International (VRX) ZALTRAP™ Editas (EDIT) BIOMARIN (BMRN) HALOZYME (HALO) Prosensa (RNA) Dendreon (DNDN) Ariad (ARIA) INNOVIVA (INVA) Galena (GALE) Sangamo (SGMO) Auspex (ASPX) Inovio (INO) Ionis (IONS) Intrexon (XON) Regeneron (REGN) Benlysta (belimumab) Ridaforolimus